ArticleScientific reports2026
Network toxicology and bioinformatic investigation of the association between Bisphenol A and endometrial cancer.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
The role of Bisphenol A (BPA) in endometrial cancer (EC) remains uncertain. In this study, we integrated toxicological prediction, network toxicology, gene expression profiling, survival analysis, and molecular docking to explore potential BPA-associated molecular features in EC. Toxicological predictions from ADMETLAB 3.0 and ProTox-3 suggested a potential affinity of BPA for estrogen receptor α (ERα), along with possible involvement in oxidative stress and mitochondrial dysfunction. Integrative database analysis identified 129 putative BPA–EC–related genes, and GO/KEGG enrichment analyses indicated enrichment in angiogenesis-related processes and dysregulation of EGFR, MAPK, and FoxO signaling pathways. Analysis of TCGA-UCEC data identified 48 differentially expressed genes, among which five genes (ESR1, NOTCH1, GABARAP, B4GALT1, and PAN3) showed significant associations with overall survival in univariate Cox regression analyses. Kaplan–Meier analysis indicated that higher expression of GABARAP and NOTCH1 was associated with poorer survival, whereas higher expression of ESR1 and B4GALT1 was associated with more favorable outcomes. External validation using the GEO dataset GSE17025 supported differential expression patterns and prognostic relevance for ESR1, PAN3, B4GALT1, and NOTCH1. Molecular docking analyses indicated theoretical structural interaction feasibility between BPA and several key proteins, based on in silico simulations. Collectively, these findings provide bioinformatic and toxicogenomic evidence suggesting potential associations between BPA exposure and EC-related molecular pathways. This study is hypothesis-generating and may help prioritize candidate genes and pathways for future experimental validation and mechanistic investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.